SCHEDULE 13D

Company

INTEGRATED BIOPHARMA INC

Filed

November 14, 2023

Accession Number

0001437749-23-031869

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →